Opportunity Radar

← Back to search

Grant

NIH Small Business Innovation Research (SBIR) Phase IIB Strategic Breakthrough Award (Parent [R44] Clinical Trial Optional)

View on Grants.gov ↗ Sign in to save

Type
Grant
Notice type
G
Agency
National Institutes of Health
Sub-agency
HHS-NIH11
Solicitation #
PA-27-101
Posted
May 28, 2026
Response due
Apr 5, 2029
Archive date
Jun 4, 2029
CFDA / Assistance listing
93.233,93.242,93.273,93.307,93.313,93.350,93.351,93.393,93.394,93.395,93.837,93.838,93.839,93.840,93.847,93.853,93.855,93.859,93.865,93.866,93.867
Contact
SEEDinfo@nih.gov
Source
Grants.gov

Description

The NIH Phase IIB Strategic Breakthrough award bridges the funding gap between the end of a Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Phase II award and commercialization. The Phase IIB Strategic Breakthrough provides previously funded NIH SBIR or STTR projects additional support for later-stage research and development (R&D).

Similar open opportunities